Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review

Myasthenia gravis (MG) is a rare autoimmune disorder caused by specific autoantibodies at the neuromuscular junction. MG is classified by the antigen specificity of these antibodies. Acetylcholine receptor (AChR) antibodies are the most common type (74–88%), followed by anti-muscle specific kinase (...

Descripción completa

Detalles Bibliográficos
Autores principales: Waheed, Waqar, Newman, Eric, Aboukhatwa, Marwa, Moin, Maryam, Tandan, Rup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288180/
https://www.ncbi.nlm.nih.gov/pubmed/35855752
http://dx.doi.org/10.2147/TCRM.S266031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288180/
https://www.ncbi.nlm.nih.gov/pubmed/35855752
http://dx.doi.org/10.2147/TCRM.S266031

Ejemplares similares